Insights From Technical Analysis

HighCom (ASX: HCL): New Defence Deal as Shares Trade in a Key Technical Zone

Oct 5, 2026

Proactive Equities Team

HighCom secured a NZ$1.96 million New Zealand Defence Force counter-drone contract, extending its regional CUAS footprint. With FY26 revenue falling sharply and shares trading near key technical levels, investors are watching whether new deal can improve the company’s outlook.

Read more

Treasury Wine Estates (ASX: TWE): $100M Climate Commitment Underpins Strategic Reset and Luxury Shift

Oct 5, 2026

Proactive Equities Team

Treasury Wine Estates' 2026 sustainability report shows lighter Penfolds bottles, $100m climate adaptation target and Barossa decarbonisation backed by ARENA, as the winemaker reshapes itself into a focused luxury business.

Read more

ArchTIS (ASX: AR9): U.S. Defence Deal and Commercial Expansion Drive 2026 Growth

Oct 5, 2026

Proactive Equities Team

ArchTIS (ASX: AR9) reported 208% ARR growth to A$14.8 million and secured a new U.S. Department of Defence services agreement while expanding into commercial aviation and banking markets.

Read more

Powerhouse Ventures (ASX: PVL): Aliwa Earn-Out Shares and Director Purchases Reshuffle Ownership

Oct 5, 2026

Proactive Equities Team

Powerhouse Ventures (ASX: PVL) issued 783,311 earn-out shares linked to its Aliwa Funds Management acquisition, and director David McNamee bought 166,689 shares, reshaping the company’s ownership structure and shareholding profile.

Read more

333D (ASX: T3D): Unaccountable Surge Draws Attention to Bitcoin-Holding Micro-Cap with A$1.8M Revenue

Oct 5, 2026

Proactive Equities Team

333D (ASX: T3D) has told ASX it knows of no undisclosed news behind its recent share price surge, putting fresh focus on its Bitcoin treasury, healthcare software push and history of volatile trading.

Read more

Hazer Group (ASX: HZR): Licensing Wins Pile Up as Shares Sit at a Key Support Level

Oct 2, 2026

Proactive Equities Team

Hazer Group (ASX: HZR) is pushing its capital-light hydrogen and graphite licensing model toward commercial execution, with a FortisBC facility underway and a new Japanese utility study won.

Read more